Women with ankylosing spondylitis more prone to Increased risk of obstetric complications, reports study

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-10-17 14:45 GMT   |   Update On 2024-10-17 14:45 GMT

A new study published in the journal of BMC Pregnancy and Childbirth showed that women with ankylosing spondylitis (AS) are more likely to experience obstetric difficulties such as caesarean delivery (CD), small-for-gestational-age (SGA) and intrauterine fetal death (IUFD).

The sacroiliac joints and spine are the main organs affected by the inflammatory, chronic, systemic illness known as ankylosing spondylitis. It is among the most prevalent seronegative spondyloarthropathies, with a significant hereditary component. Many autoimmune illnesses exhibit a modification of their disease activity during pregnancy. Contrary to rheumatoid arthritis, the majority of AS patients are in an active state of illness when they get pregnant, and pregnancy has no discernible positive impact on the disease activity of AS. Also, most AS patients experience a postpartum exacerbation of disease activity between six weeks and six months following birth.

Limited research with small sample numbers has examined how AS affects fetal and neonatal outcomes. Despite this condition being not rare among women of reproductive age, research on pregnancy outcomes has yielded mixed results. Thereby, Uri Amikam and his team conducted this study to assess pregnancy and perinatal outcomes in women with and without AS.

This retrospective cohort research utilized the Nationwide Inpatient Sample (HCUP-NIS) of the Healthcare Cost and Utilisation Project. All expectant mothers who gave birth or had a maternal death in the United States between 2004 and 2014 were included in the study. Before or during pregnancy, women having an ICD-9 diagnosis of AS were compared to the individuals who did not. Using multivariate logistic regression models that controlled for relevant confounders, delivery, pregnancy, and neonatal results were compared between the two groups.

Advertisement

A total of 9,096,788 women in all were included in the analysis. Of these, 383 women (3.8/100,000) were diagnosed with AS, while the remaining women served as controls. The women with AS were more likely to be older, Caucasian, originate from higher income quartiles, have thyroid issues, and become pregnant more than once when compared to women without AS.

When compared to the women without AS, the patients in the AS group showed greater rates of placenta previa, gestational diabetes, and caesarean delivery (CD) after controlling for variables. In terms of newborn outcomes, there was a greater incidence of small-for-gestational-age neonates and intrauterine fetal death in individuals with AS as opposed to those without. Overall, in addition to a higher risk of SGA and IUFD, women with AS are more likely to experience obstetric problems, such as CD.

Source:

Amikam, U., Badeghiesh, A., Baghlaf, H., Brown, R., & Dahan, M. H. (2024). Obstetric and neonatal outcomes in women with Ankylosing spondylitis - an evaluation of a population database. In BMC Pregnancy and Childbirth (Vol. 24, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1186/s12884-024-06833-0

Tags:    
Article Source : BMC Pregnancy and Childbirth

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News